BIT's 13th Annual World Cancer Congress-2020（WCC-2021）

★ Scientific Program

Preliminary Program

Keynote Forum

Time: 09:30-11:50, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
09:30-09:45	Opening Ceremony
09:45-10:10		Speech Opportunity Available Abstract and Biography: Submit Here
10:10-10:35		Speech Opportunity Available Abstract and Biography: Submit Here
10:35-11:00		Title: The Evolution of Cardiovascular Robotics in the Catheterization Laboratory Dr. Rafael Beyar, Professor, Rambam Health Care Campus and the Technion, Israel
11:00-11:25		Title: Oral Bacterial Infections and Cancer Dr. Jukka H. Meurman, Professor, Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Finland
11:25-11:50		Title: Histology Guided Mass Spectrometry in the Diagnosis of Malignant Melanoma Dr. Rossitza Lazova, Director, California Skin Institute, San Diego, California, USA

Track 1-1: Molecular Carcinogenesis, Oncogenes and Tumor Suppressors in Cancer

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Sinerik Ayrapetyan, Professor, UNESCO Chair-Life Sciences International Postgraduate Educational Center, Coordinator of UNESCO/UNITWIN Interregional Network on PhD Education and Research in Biophysics, Biotechnology and Environmental Health, Armenia Co-chair: Dr. Sharad Khare, Professor & Director Gastrointestinal Cancer Research, Department of Internal Medicine, University of Missouri, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: TBD Dr. Sinerik Ayrapetyan, Professor, UNESCO Chair-Life Sciences International Postgraduate Educational Center, Coordinator of UNESCO/UNITWIN Interregional Network on PhD Education and Research in Biophysics, Biotechnology and Environmental Health, Armenia
14:30-14:55		Title: Role of Genomic Instability in Colorectal Cancer Dr. A. Yadav, Sanjay Gandhi Postgraduate Institute of Medical Sciences, India
14:55-15:20		Title: Stress induced Long Noncoding RNAs in Cell Survival and Proliferation Dr. Eitan Shaulian, Head of Department of Biochemistry and Molecular Biology, Hebrew University Medical School, Israel
15:20-15:45		Title: Sprouty: An Oncogene or Tumor Suppressor Gene in Colorectal Cancer Dr. Sharad Khare, Professor & Director Gastrointestinal Cancer Research, Department of Internal Medicine, University of Missouri, USA
15:45-16:00	Coffee Break
16:00-16:25		Title: IL6R-STAT3-ADAR1(P150) Interplay Promotes Oncogenicity In1q21(Amp) Multiple Myeloma Dr. Phaik Ju Teoh, Senior Research Scientist, National University Health System, Singapore
16:25-16:50		Title: Proteins in Soy Might Have a Higher Role in Cancer Prevention than Previously Expected: Soybean Protein Fractions are More Effective MMP-9 Inhibitors than Non-Protein Fractions, Even in Cooked Seeds Dr. Joana Mota, Instituto Superior de Agronomia, Universidade de Lisboa, Portugal
16:50-17:15		Title: DEAD-box RNA Helicase DP103 Predicts Statin Sensitivity in Triple Negative Breast Cancer Dr Alan Prem Kumar, Principal Investigator, National University of Singapore, Singapore
17:15-17:40		Speech Opportunity Available Abstract and Biography: Submit Here

Track 1-2: Cancer Genetics, Genomics and Epigenetics

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Joseph De Soto, University Professor, Dine College, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: ATF4-dependent Regulation of the NRF2-mediated Antioxidant Protection. A Novel Mechanism Promoting Survival Upon Endoplasmic Reticulum Stress Dr. Cédric Chaveroux, Leader of the “Nutritional Stress Response” Group, Cancer Research Center of Lyon, France
14:55-15:20		Title: Genome-wide Methylotyping Resolves Breast Cancer Epigenetic Heterogeneity and Suggests Novel Therapeutic Perspectives Dr. Vladimir Strelnikov, Head of Epigenetics Lab, Research Centre for Medical Genetics, Russia
15:20-15:45		Title: Transient Receptor Potential A1-induced Necrosis in Melanoma Cells Via Phospholipase D Dr. Rei Nakano, Special Postdoctoral Researcher, RIKEN Center for Integrative Medical Sciences/Nihon University, Japan
15:45-16:00	Coffee Break
16:00-16:25		Title: Mutational Profiling of Malignant and Benign Thyroid Neoplasms with Targeted High-Throughput Sequencing Dr. Valentina Yakushina, Senior Researcher, Research Centre for Medical Genetics, Russia
16:25-16:50		Title: Expression and CpGisland Methylation of Leukotriene Receptors LTB4R and LTB4R2 as Prognostic and Predictive Marker For Breast Cancer Dr. Alexey Kalinkin, Research Associate, Research Centre for Medical Genetics, Russia
16:50-17:15		Title: The Selective Targeting of Cancer via Deficits in Homologous Recombination Dr. Joseph De Soto, University Professor, Dine College, USA
17:15-17:40		Title : Association Between Molecular Genetic Markers of DNA Repair and Cell Circle Control Genes and Progression-Free Survival of Patients with Ovarian Cancer After Platinum-Based Chemotherapy Dr. Tatiana M. Zavarykina, N. M. Emanuel Institute of Biochemical Physics, Russian Academy of Sciences, Russia

Track 2-1: Cancer Prognostic Biomarkers and Predictive Factors

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Darius M. Dziuda, Professor of Data Science and Statistics, Department of Mathematical Sciences, Central Connecticut State University, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: TBD Dr. Beiyun Chen, Section Head of Breast Pathology, Mayo Clinic, USA
14:30-14:55		Title: Using an Integrated Multiplexing Approach to Identify Prognostic Biomarkers in Rare Ovarian Granulosa Cell Tumors Dr. Anna Juncker-Jensen, Senior Scientist,, NeoGenomics,USA
14:55-15:20		Title: Early Detection of Leukemia using A Novel Biochemical Blood Test and Multivariate Analysis Dr. Shaul Mordechai, Professor & Head, Biomedical Spectroscopy, Ben Gurion University, Israel
15:20-15:45		Title: Frailty Index to Predict Survival and 30-Day Readmission in Cancer Patients with an Unplanned Hospitalization: An Observational Cohort Study Dr. Timothy N Hembree, Assistant Professor, University of South Florida, USA
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Javier Camacho, Centro de Investigacion y Estudios Avanzados del IPN, Mexico
16:25-16:50		Speech Opportunity Available Abstract and BiographySubmit Here
16:50-17:15		Title : Effects of FGFR3 and PIK3CA mutation prognosis of bladder carcinoma Dr. Jian Zhong, Deputy Chief Physician, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, China
17:15-17:40		Title: The Role of Preventing Hypoxia for Developing of Fatal Complications to Oncology Patients Dr. Yury Udalov, Deputy Director General of Medical Department, Head of the Occupational Pathology Center, State Research Center – Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency (SRC-FMBC), Russia

Track 3-1: Radiotherapy

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Call for Chair
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Adding CD96 to Our Warchest of Cancer Checkpoint Dr. John J Miles, Professor, James Cook University, Australia
14:30-14:55		Title: A Surgeon’s Perspective on the Past, Present and Future of Radiotherapy for Cancer Dr. Darius S. Francescatti, Associate Professor, Rush University Medical Center, USA
14:55-15:20		Title: New Method of Measurements of the Isocenter of a Linear Accelerator Dr. Pawe?Kuko�owicz, Professor, Maria Sklodowska-Curie National Research Institute of Oncology, Naviration Ltd. Company, Poland
15:20-15:45		Title: TBD Dr. Duong Duc Binh, Times City International Hospital, Vietnam
15:45-16:00	Coffee Break
16:00-16:25		Title : Future Trends Radiotherapy in Localized Prostate Cancer Dr. Maria Tolia, Assistant Professor, University of Thessaly, Greece
16:25-16:50		Title: TBD Dr. Franco Campostrini, "Mater Salutis" Hospital, Italy
16:50-17:15		Speech Opportunity Available Abstract and BiographySubmit Here
17:15-17:40		Title: TBD Dr. Isabel Almeida, Department of Radiation Oncology (MAASTRO), GROW – School for Oncology and Developmental Biology, Maastricht University Medical Center, the Netherlands

Track 3-2: Chemotherapy and Photodynamic Therapy

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Emil Toma, Full Clinical Professor, University of Montreal, Canada
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Antiretrovirals for Cancer Treatment: A Revitalizing Attempt Dr. Emil Toma, Full Clinical Professor, University of Montreal, Canada
14:30-14:55		Speech Opportunity Available Abstract and Biography: Submit Here
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Title: Endogenous Protoporphyrin IX – A New Potential Photosensitizer for Photodynamic Therapy Dr. Louri Borissevitch, Full professor, São Paulo University, Institute of Physics – Goiás Federal University, Brazil
15:45-16:00	Coffee Break
16:00-16:25		Title: Synthesis, DNA interaction, In Vitro/In Silico Topoisomerase II Inhibition and Photodynamic Therapy Activities of Two Cationic BODIPY derivatives Dr. Ozlem Coban, Assistant Professor, Karadeniz Technical University, Turkey
16:25-16:50		Title: Anti-tumor Effect of Chitin Degradation Products in Vitro and in Vivo Xing Liu, Attending doctor, General Hospital of Northern Theater Command, and Thai Full Rich Medical Center, China
16:50-17:15		Title: Latest In Enhancing The Effect Of Chemotherapy And Anti Hormonal Therapy In Resistant Breast Cancer Dr. Mohamed El-Sheemy, Research Development, Lincoln County Hospital, UK
17:15-17:40		Title: Ponatinib Induces a Sustained Deep Molecular Response in a Chronic Myeloid Leukaemia Patient with an Early Relapse with a T315I Mutation Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report Dr. Rosa Branca Ferreira, Portuguese Oncology Institute, Porto, Portugal

Track 4-1: Anticancer Drug Discovery, Design, and Optimization

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Takashi Owa, Corporate Officer, Vice President, Eisai Oncology Business Group, Eisai Inc., USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: Identification of a Novel Sulfonamide Class of Molecular Glue That Induces Selective Degradation of Splicing Factor RBM39 via CUL4-DCAF15 Ubiquitin Ligase Dr. Takashi Owa, Corporate Officer, Vice President, Eisai Oncology Business Group, Eisai Inc., USA
14:55-15:20		Speech Opportunity Available Abstract and Biography: Submit Here
15:20-15:45		Title: Microenvironment-Controlled 3D Cell Systems With Super-Resolution Optics and Intelligent Computation for Effect Drug Screening Dr. Jung-Hsin Lin, National Taiwan University, Taiwan
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Zvi Naor, Professor, Tel Aviv University, Israel
16:25-16:50		Title: Electronic Water can Reduce Oxidative Stress in Cancer and Diabetes Patients for 3 Weeks Drinking Dr. Masahiro Onuma, President, Trisguide Ltd., Japan
16:50-17:15		Title: Halloysite Nanotubes as Carriers for Irinotecan: Synthesis and Characterization by Experimental and Molecular Simulation Methods Dr. Miroslav Pospisil, Researcher, Charles University, Czech Republic
17:15-17:40		Title: Curcumin Co-treatment Ameliorates Resistance to Gefitinib in Drug- resistant NCI-H1975 Lung Cancer Cells Dr. Weiping Zhang, Director, The Third Affiliated Hospital of Zhejiang Chinese Medical University, China

Track 5-1: Head, Neck, Brain Cancers, and CNS Tumors

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Allen Fred Fielding, Professor, Temple University Hospital, Medical School and School of Dentistry, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:25		Title: Osteonecrosis of the Jaw and Possible Solutions for Prevention Dr. Allen Fred Fielding, Professor, Temple University Hospital, Medical School and School of Dentistry, USA
14:25-14:45		Title: Magnetic Resonance guided Laser Induced Thermal Therapy (MRgLITT) for Cadaveric Reanimation: A Large Prospective Study Dr. Nitesh V Patel, Department of Neurosurgery, Rutgers – University Hospital, Rutgers New Jersey Medical School, USA
14:45-15:05		Title: What is the role of Circulating Tumour Cells in Nasopharyngeal Carcinoma Dr. Yuan Wu,Vice Director, Hubei Cancer Hospital, China
15:05-15:25		Title : Cutanea Oncology - Rare Skin Tumors Dr. Elder Feltrim, Tocantins State Health Secretariat, Brazil
15:25-15:45		Speech Opportunity Available Abstract and Biography: Submit Here
15:45-16:00	Coffee Break
16:00-16:20		Title: Glioblastoma, A Paradigm of Aggressiveness and Recurrence.RNA Interference-Based Therapy Addressing Lipid Metabolism Combined with New Generation Chemotherapeutics Dr. Amalia S. Jurado, University of Coimbra, Portugal
16:20-16:40		Title: Extra-parenchymal (Peripheral) Atypical Teratoid / Rhabdoid Tumors Dr. Hidehiro OKA, Professor, Kitasato University Medical Center, Japan
16:40-17:00		Title: Usefulness of New Method Using Absorbable Sealing Materials and Fibrin Glue to Wound of Partial Glossectomy Dr. Masahiro Iwata, Freelance Maxillofacial Surgeon, Uji Tokushukai Hospital, Japan
17:00-17:20		Title : One Yearexperience in Radio-Oncology on Halcyon 2.0 in the DemocraticRepublic of Congo Dr. Abou Dao, Hôpital de District de Bogodogo, Burkina Faso

Track 5-2: Lung Cancer/Other Thoracic Cancers

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Olivier E Pardo, Team Leader, Imperial College, Division of Cancer, UK
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Speech Opportunity Available Abstract and Biography: Submit Here
14:30-14:55		Title: The Changing Role for the Thoracic Surgeron in Stage IIIa Lung Cancer Dr. Edward Black, Nottingham City Hospital, UK
14:55-15:20		Title: Targeting RSK4 Prevents both Chemoresistance and Metastasis in Lung and Bladder Cancer: Potential of Re-purposed Floxacins as Novel Therapeutic Agents Dr. Olivier E Pardo, Team Leader, Imperial College, Division of Cancer, UK
15:20-15:45		Title: TBD Dr. Chang Shu, Director & Professor, FuwaiHospital, Chinese Academy of Medical Sciences, China
15:45-16:00	Coffee Break
16:00-16:25		Title: TBD Dr. Jaroslaw Kuzdzal, Pulmonary Hospital Zakopane, Poland
16:25-16:50		Title: Video-assisted Thoracic Surgery in Advanced Non-Small Cell Lung Cancer Treatment Dr. Anil Gokce, Thoracic Surgeon, University of Health Sciences, Ankara City Hospital, Turkey
16:50-17:15		Title: TBD Dr. Ricardo Buitrago, National Cancer Institute, Colombia
17:15-17:40		Title: Lung Cancer Dr. Abed Agbarya, Institute of Oncology, Bnai Zion Medical Center, Israel

Track 6-1: Cancer Rehabilitation, Cancer Nursing and Care

Time: 14:00-17:40, July 20, 2021 (Tuesday); Place: Lisbon, Portugal

Chair: Dr. Asha Ramsakal, Chair of Medicine, Moffitt Cancer Center, USA
Time	FaceOn	Speeches and Speakers
14:00-14:05	Chair's Introduction
14:05-14:30		Title: Consensus Protocols for the Diagnosis and Management of the Hereditary Autoinflammatory Syndromes CAPS, TRAPS and MKD/HIDS: a German PRO-KIND Initiative Dr. Jasmin Kümmerle-Deschner,Professor University Children's Hospital Tuebingen, Germany
14:30-14:55		Title: Is Immunosuppressive Therapy the Most Common Method of Management Dr. Inessa Kononenko, Executive Director, The Society of Supportive care in Oncology (RASSC), Russia
14:55-15:20		Title: Return to Work Interventions for Cancer Survivors : What Interventions? What Impacts ? Dr. Jérôme Foucaud, Health Education and Practices Laboratory (LEPS EA 3412), Paris 13 University-UFR SMBH, 93017 Bobigny, France
15:20-15:45		Title: Cancer: Personal, Professional, and Practice Impact Dr. Asha Ramsakal, Chair of Medicine, Moffitt Cancer Center, USA
15:45-16:00	Coffee Break
16:00-16:25		Title :An Examination of the Quality of Life and Unmet Supportive Care Needs In Haematological Cancer Survivors Ms. Anita Immanuel, PhD Candidate, Bournemouth University, UK
16:25-16:50		Title: Cancer Fatigue - in The Oncological Rehabilitation We Work Against It Dr. Birgit Leibbrand, Medical Director, Salzetalklinik, Onkologische Rehabilitation, Germany
16:50-17:15		Title: How do a new advanced nursing role impact patients perception of cancer care? Dr. Bodil Westman, Registered Nurse, Regional Cancer Centre Stockholm Gotland, Sweden
17:15-17:40		Title: Perioperative Anesthestic Care: Evidence in Oncologic Outcome Dr. Anoushka M. Afonso, Director of Enhanced Recovery Programs (ERPs), Memorial Sloan Kettering Cancer Center, USA

Hosting Organization

BIT Group Global Ltd.

Supporting Organization

WIN Consortium

The Society of Supportive Care in Oncology

International Honorary Chairmen

Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France

Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA

Overseas Cooperate Medias and Journals